pharmaceutical nanotechnology Archives - USF Health News /blog/tag/pharmaceutical-nanotechnology/ USF Health News Fri, 30 Jun 2023 20:30:38 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.5 TCOP and Florida Education Fund partner for STEM opportunity /blog/2023/06/27/tcop-and-florida-education-fund-partner-for-stem-opportunity/ Tue, 27 Jun 2023 14:38:39 +0000 /?p=38158                             The USF Health Taneja College of Pharmacy (TCOP) partnered with the Florida Education Fund […]

]]>

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The USF Health Taneja College of Pharmacy (TCOP) partnered with the Florida Education Fund for a unique opportunity for masters-level students that aims to address the underrepresentation of African American, Hispanic, and female masters-level student populations in STEM related programs and careers.

Called the McKnight Graduate NANO-STEM Fellowship, this new program is based in TCOP and provides recipients with a $15,000 stipend toward their tuition as they pursue their Master of Science in Pharmaceutical Nanotechnology.

“Over the next seven to 10 years, there is going to be a dire need for STEM graduates in the country,” said Shyam Mohapatra PhD, MBA, TCOP graduate programs associate dean. “The Florida Education Fund has always been at the forefront of advancing educational opportunities for historically underrepresented groups.  This is a perfect match for us since we just achieved a STEM designation.”

Three stipends will be awarded annually to applicants who are:

  • African American, Hispanic and/or female
  • U.S. citizen or permanent resident with proof of Florida residency
  • Accepted into the TCOP Master of Science in Pharmaceutical Technology program
  • A fulltime student with intent to pursue a PhD in a STEM field at a university in Florida

Applicants must submit the following in addition to their online application:

  • Resume or curriculum vitae
  • Official transcripts from each institution attended
  • Three letters of recommendation from individuals who can speak to the applicant’s academic potential
  • Completed Florida residency affidavit

Recipients must agree to the stipulation in the award agreement that requires them to present their research at McKnight conferences, regularly update their program directory information, and complete periodic surveys as requested by the FEF.

In addition to financial relief, McKnight Fellows are also more likely to:

  • Become competitive applicants for doctoral programs and their post-graduate careers
  • Receive additional resources and gain exposure to invaluable professional networks
  • Engage in unique opportunities related to pharmaceutical nanotechnology

All applicants must have all documents submitted to the FEF July 15, 2023.  For more information and instructions on the application process visit https://fefonline.org/gnsf.html



]]>
USF Pharmacy announces initiatives to advance innovation and technology in learning and discovery /blog/2018/02/22/usf-pharmacy-announces-initiatives-advance-innovation-technology-learning-discovery/ Fri, 23 Feb 2018 01:16:54 +0000 /?p=24226 The Healthcare Imaginarium for Exponential Technologies, or HIETs™ is the brainchild of visionary College of Pharmacy Dean Kevin Sneed TAMPA, Fla. (Feb. 22, 2018) — USF Health’s Pharmacy […]

]]>

The Healthcare Imaginarium for Exponential Technologies, or HIETs™ is the brainchild of visionary College of Pharmacy Dean Kevin Sneed

Kevin Sneed, PharmD, (standing right) dean of the USF College of Pharmacy, spoke about how exciting new technologies would be integrated into the college’s currriculum starting this fall.

TAMPA, Fla. (Feb. 22, 2018) — USF Health’s Pharmacy Dean Kevin Sneed, PharmD, announced this week several key initiatives intended to integrate advanced technologies into the student curriculum and to keep the college at the cutting-edge of innovation in education, research and patient care. He spoke Feb. 20 to a gathering of business and community leaders, as well as students, faculty and staff.

“We want our USF College of Pharmacy to remain relevant not only today, but for the next 25 years,” Dr. Sneed said.  “Right from the beginning, our mission has been to revolutionize health through innovation and empowerment… Now is the time to reimagine what education will be moving into the future.”

The initiatives are part of a newly created Healthcare Imaginarium for Exponential Technologies™ or HIETs™.   They include the introduction in fall 2018 of virtual reality content to supplement existing curriculum and help make the learning experiences of USF pharmacy students more immersive and life-like than textbooks, online content and traditional videos.

Many of those gathered used mobile device technology to record the event.

Students will put on special eyewear to view computer-generated images they could interact with. So for instance, they might experience in 360-degree, three-dimensional context the growth of plaques in coronary arteries and what happens when a stent is inserted to clear a clogged artery.  In yet-to-be-developed ways, virtual reality technology may also seamlessly combine pharmacology with physiology to simulate the effects of treatment. For example, students could visualize in real-time the action on smooth muscle airways when a bronchodilator drug is inhaled by an asthma patient. Such advanced technology could also be harnessed by health professionals as a more engaging way to educate patients about their diagnoses and care, Dr. Sneed said.

The College of Pharmacy plans to work with MediaLab 3D Solutions, a Tampa-based digital content creator, and BioLucid, a digital health company recently acquired by Sharecare, to develop a combination of virtual, augmented and mixed reality content.

USF pharmacy student Natalie Dehaney demonstrates how virtual reality technology allows students to visualize what happens inside the body when a patient experiences atrial fibrillation. She can trigger and replay the simulation of electrical conduction in the heart. 

MediaLab CEO Bruce VanWingerden said the project will be the first time the company, which works with major corporations, has ventured into academia. “This is an exciting opportunity to work with Dr. Sneed and his staff to really look at different ways to present in a new and exciting fashion information that can be difficult to convey,” VanWingerden said. “We want to take all the innovative technology and make it easy to use to further the educational process.”

Laysa Mena, a student delegate for the College of Pharmacy, describes herself as a “visual learner” who absorbs more by seeing than reading. “So I feel implementing virtual reality with our curriculum would be very beneficial and give us a better appreciation of how drugs work in the body,” she said.

Dr. Sneed announced a key initiative known as the Botanical Medicinal Research Consortium, which will team USF researchers and clinicians with local companies to conduct evidence-based  clinical research on whether non-euphoric forms of cannabis may benefit patients with certain diseases.

Another key initiative, known as the Botanical Medicinal Research Consortium, or BMRC, will bring together researchers and clinicians in USF’s colleges of pharmacy and medicine, the university’s Center for Drug Discovery & Innovation, and businesses in Tampa Bay and beyond to conduct rigorous studies on the safety and effectiveness of medical cannabis and other plant derivatives.

Many unanswered questions remain about the potential of cannabinoids, the active chemical found in the plant and elsewhere, to treat various diseases or conditions like chronic pain. The USF College of Pharmacy wants to take the lead in conducting top-quality research on medical cannabis and find the correct noneuphoric formulations that may benefit patients and their overall health, Dr. Sneed said.

Mark Kindy, PhD (left), professor of pharmaceutical sciences, is the College of Pharmacy’s liaison for the Botanical Medicinal Research Consortium, and Kevin Olson, PharmD, MBA, assistant professor of biopharmaceutics and clinical research, is the liaison for the Entreprenerial Academy, a collaboration with the Muma College of Business. 

“Plant-derived compounds are the future of medicine, and we’re looking forward to collaborating with the University of South Florida in this area,” said Garyn Angel, chief strategy officer for ANANDA Scientific, a company that produces nonpsychoactive and nonabusive oral cannabinoid health products. “Evidence-based clinical research is needed for cannabinoids to enter Western medicine.”

Dr. Sneed also announced that the BMRC would collaborate with the UCLA Cannabis Research Initiative at the UCLA Semel Institute for Neuroscience and Human Behavior, one of the first academic programs dedicated to investigating cannabis to lead public policy and public health decisions.

Other HIETs initiatives include:

  • With the College of Engineering, USF Pharmacy will work to advance personalized medicine that tailors therapy based on an individual’s genetic makeup. As the technology of medicine and drug development continues to shrink down to the nanoscale, USF has also started a Pharmaceutical Nanotechnology master’s program to teach students how to deliver medications in new, more precise ways.

 

  • The College of Pharmacy will join forces with the Muma College of Business to create an Entrepreneurial Academy that inspires innovation and start-up companies.  The aim is to help pharmacists think like entrepreneurs so they can better enhance heath care outcomes and cost-effectiveness.

 

  • Clinical trials: Through its WE-CARE program (Workgroup Enhancing Community Advocacy and Research Engagement), the College of Pharmacy partners with key stakeholders to increase participation of minority and medically underserved populations in clinical trials.  The program seeks to ensure that all communities have access to genomic clinical research as technology advances.

-Photos by Torie Doll, USF Health Communications and Marketing

 



]]>